Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol ER Conversion in Chronic Pain
NCT01631513Phase 4Withdrawn
- Sponsor
- Janssen Scientific Affairs
- Start
- Aug 2012
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tapentadol in chronic low back pain (CLBP), osteoarthritis (OA), sponsored by Janssen Scientific Affairs. Planned start Aug 2012; status: withdrawn.
02
Drugs
tapentadol
03
Conditions
chronic low back pain (CLBP)osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01631513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01631513.